cells r d systems af1157 goat polyclonal (R&D Systems)
Structured Review
Cells R D Systems Af1157 Goat Polyclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti+mouse+ngfr+polyclonal+antibody/Mouse+NGFR%2FTNFRSF16+Antibody/pm39695302-438-71-72
Average 94 stars, based on 43 article reviews
Images
Related Articles
other:Article Title: The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells. Article Snippet: Used antibodies were as follows: Immunohistochemistry:Article Title: A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells Article Snippet: Immunohistochemistry was performed with rabbit antimouse gp100 polyclonal antibody (Novus Biologicals; NBP169571) and goat anti-mouse NGFR polyclonal antibody (R&D Systems; BAF1157), followed by enzyme-conjugated secondary antibodies and the LSAB-2 color development system (DAKO). Article Title: Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Article Snippet: Adoptive cell transfer therapies (ACTs) with cytotoxic T cells that target melanocytic antigens can achieve remissions in patients with metastatic melanomas, but tumours frequently relapse.. Hypotheses explaining the acquired resistance to ACTs include the selection of antigen-deficient tumour cell variants and the induction of T-cell tolerance.. However, the lack of appropriate experimental melanoma models has so far impeded clear insights into the underlying mechanisms. Article Title: A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells Article Snippet: Human melanomas exhibit considerable genetic, pathological, and microenvironmental heterogeneity.. Genetically engineered mice have successfully been used to model the genomic aberrations contributing to melanoma pathogenesis, but their ability to recapitulate the phenotypic variability of human disease and the complex interactions with the immune system have not been addressed.. Here we report the unexpected finding that immune-cell poor pigmented and immunecell rich amelanotic melanomas developed simultaneously in Cdk4R24C mutant mice upon melanocyte-specific conditional activation of oncogenic BrafV600E and a single application of the carcinogen DMBA. |

